1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Market Perspective (2016-2027)
2.2 Peptide Therapeutics Growth Trends by Regions
2.2.1 Peptide Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Peptide Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Peptide Therapeutics Industry Dynamic
2.3.1 Peptide Therapeutics Market Trends
2.3.2 Peptide Therapeutics Market Drivers
2.3.3 Peptide Therapeutics Market Challenges
2.3.4 Peptide Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Therapeutics Players by Revenue
3.1.1 Global Top Peptide Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide Therapeutics Revenue
3.4 Global Peptide Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Revenue in 2020
3.5 Peptide Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Therapeutics Breakdown Data by Type
4.1 Global Peptide Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Peptide Therapeutics Forecasted Market Size by Type (2022-2027)
5 Peptide Therapeutics Breakdown Data by Application
5.1 Global Peptide Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Peptide Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peptide Therapeutics Market Size (2016-2027)
6.2 North America Peptide Therapeutics Market Size by Type
6.2.1 North America Peptide Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Peptide Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Peptide Therapeutics Market Size by Type (2016-2027)
6.3 North America Peptide Therapeutics Market Size by Application
6.3.1 North America Peptide Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Peptide Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Peptide Therapeutics Market Size by Application (2016-2027)
6.4 North America Peptide Therapeutics Market Size by Country
6.4.1 North America Peptide Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Peptide Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peptide Therapeutics Market Size (2016-2027)
7.2 Europe Peptide Therapeutics Market Size by Type
7.2.1 Europe Peptide Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Peptide Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Peptide Therapeutics Market Size by Type (2016-2027)
7.3 Europe Peptide Therapeutics Market Size by Application
7.3.1 Europe Peptide Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Peptide Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Peptide Therapeutics Market Size by Application (2016-2027)
7.4 Europe Peptide Therapeutics Market Size by Country
7.4.1 Europe Peptide Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Peptide Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Peptide Therapeutics Market Size by Type
8.2.1 Asia-Pacific Peptide Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide Therapeutics Market Size by Application
8.3.1 Asia-Pacific Peptide Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide Therapeutics Market Size by Region
8.4.1 Asia-Pacific Peptide Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide Therapeutics Market Size (2016-2027)
9.2 Latin America Peptide Therapeutics Market Size by Type
9.2.1 Latin America Peptide Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Peptide Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Peptide Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Peptide Therapeutics Market Size by Application
9.3.1 Latin America Peptide Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Peptide Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Peptide Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Peptide Therapeutics Market Size by Country
9.4.1 Latin America Peptide Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Peptide Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Peptide Therapeutics Market Size by Type
10.2.1 Middle East & Africa Peptide Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide Therapeutics Market Size by Application
10.3.1 Middle East & Africa Peptide Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide Therapeutics Market Size by Country
10.4.1 Middle East & Africa Peptide Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide Therapeutics Introduction
11.1.4 Sanofi Revenue in Peptide Therapeutics Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide Therapeutics Introduction
11.2.4 Teva Revenue in Peptide Therapeutics Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide Therapeutics Introduction
11.4.4 Takeda Revenue in Peptide Therapeutics Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Peptide Therapeutics Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Peptide Therapeutics Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide Therapeutics Introduction
11.7.4 Novartis Revenue in Peptide Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide Therapeutics Introduction
11.8.4 AbbVie Revenue in Peptide Therapeutics Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide Therapeutics Introduction
11.9.4 Ipsen Revenue in Peptide Therapeutics Business (2016-2021)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide Therapeutics Introduction
11.10.4 Ferring Revenue in Peptide Therapeutics Business (2016-2021)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide Therapeutics Introduction
11.11.4 Merck Revenue in Peptide Therapeutics Business (2016-2021)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide Therapeutics Introduction
11.12.4 The Medicines Revenue in Peptide Therapeutics Business (2016-2021)
11.12.5 The Medicines Recent Development
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Peptide Therapeutics Introduction
11.13.4 J & J Revenue in Peptide Therapeutics Business (2016-2021)
11.13.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
